🔎 Trials Near Me

Hem › Burkitts lymfom › South Carolina

Kliniska studier för Burkitts lymfom i South Carolina

5 studier för Burkitts lymfom söker deltagare vid platser i South Carolina.

Städer i South Carolina

Officiell studietext (engelska)

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

  • Prisma Health Cancer Institute - Spartanburg, Boiling Springs
  • Prisma Health Richland Hospital, Columbia
  • Prisma Health Cancer Institute - Easley, Easley
  • och 8 fler
RekryterarFas 3
Ålder 18 till 39 · Alla kön · Uppdaterad 2 okt. 2026 · NCT03150693

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

  • Prisma Health Richland Hospital, Columbia
  • BI-LO Charities Children's Cancer Center, Greenville
RekryterarFas 2
365 Days · Alla kön · Uppdaterad 25 sep. 2026 · NCT06317662

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

  • Prisma Health Richland Hospital, Columbia
  • BI-LO Charities Children's Cancer Center, Greenville
  • Prisma Health Cancer Institute - Eastside, Greenville
RekryterarFas 2
Ålder 1 till 30 · Alla kön · Uppdaterad 1 sep. 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

  • Medical University of South Carolina, Charleston
  • Prisma Health Richland Hospital, Columbia
  • BI-LO Charities Children's Cancer Center, Greenville
RekryterarFas 3
365 Days – 25 Years · Alla kön · Uppdaterad 25 aug. 2026 · NCT03959085

Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.